Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Malignant Lymphoma

Free Subscription 10.11.2025 3 Blood 1 BMC Cancer 1 Br J Haematol 1 Eur J Haematol 2 Haematologica 1 Int J Cancer 1 Leuk Lymphoma 2 Leukemia 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. FOURNIER B, Latour S
   Methylation profiling: unmasking CAEBV's lymphoma connection.
   Blood. 2025;146:2279-2280.
   PubMed        
   
   
2. ELSHARAWI I, Selegean S
   Classic Hodgkin lymphoma with signet ring cell morphology mimicking adenocarcinoma.
   Blood. 2025;146:2370.
   PubMed        
   
   
3. JAWOREK CP, Brockelmann PJ
   Feasibility and Safety of Anti-PD1 First-Line Treatment of Classic Hodgkin Lymphoma: Do We See the Full Picture?
   Blood. 2025 Nov 1:blood.2025029935. doi: 10.1182/blood.2025029935.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. PAN L, Lin W, Qiu Y, Chen J, et al
   Development and internal validation of a lymphoma-specific nomogram for predicting venous thromboembolism: a retrospective cohort of 790 patients.
   BMC Cancer. 2025;25:1720.
   PubMed         Abstract available
   
   

   
   Br J Haematol

5. HARROP S, Minson A, Steiner TM, Neeson PJ, et al
   Bispecific antibody combination therapies in diffuse large B-cell lymphoma.
   Br J Haematol. 2025 Nov 7. doi: 10.1111/bjh.70228.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

6. PICARDI M, Vincenzi A, Giordano C, Pugliese N, et al
   Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.
   Eur J Haematol. 2025 Nov 6. doi: 10.1111/ejh.70060.
   PubMed         Abstract available
   
   

   
   Haematologica

7. LOH Z, Yeh P, Keane C, Hawkes EA, et al
   Advances in biomarkers for mantle cell lymphoma in the era of targeted therapies.
   Haematologica. 2025 Nov 6. doi: 10.3324/haematol.2025.288185.
   PubMed         Abstract available
   
   
8. PATEL J, Gopal A, Cherniawsky H, Ram R, et al
   CD19 directed CAR T therapy for intravascular large B-cell lymphoma.
   Haematologica. 2025 Nov 6. doi: 10.3324/haematol.2025.288838.
   PubMed         Abstract available
   
   

   
   Int J Cancer

9. EKBERG S, Glimelius I, Albertsson-Lindblad A, Smedby KE, et al
   Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma.
   Int J Cancer. 2025 Nov 5. doi: 10.1002/ijc.70220.
   PubMed         Abstract available
   
   

   
   Leuk Lymphoma

10. TOUMEH N, Larson M, Negaard B, Casulo C, et al
    Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study.
    Leuk Lymphoma. 2025 Nov 3:1-8. doi: 10.1080/10428194.2025.2582721.
    PubMed         Abstract available
    
    

    
    Leukemia

11. KHOUJA M, Genuardi E, Ferrero S, Laqua A, et al
    Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.
    Leukemia. 2025 Nov 3. doi: 10.1038/s41375-025-02787.
    PubMed         Abstract available
    
    
12. THAPA R, Nichols KE, Sharma R
    Insights into germline predisposition to pediatric lymphoid malignancies.
    Leukemia. 2025;39:2590-2602.
    PubMed         Abstract available
    
    

    
    PLoS One

13. ZHOU M, Jiang C, Su C
    Exploration of adverse event profiles for glofitamab: A disproportionality analysis using the FDA adverse event reporting system.
    PLoS One. 2025;20:e0336151.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

14. LIN M, Li G, Tang X, Li R, et al
    A viral Cyclin D homolog protein hijacks the metabolic stress sensor SESN2 to promote primary effusion lymphoma growth.
    Proc Natl Acad Sci U S A. 2025;122:e2520925122.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

15. LAM EK, Luk MY, Yuen KK, Cheung BM, et al
    Bridging radiotherapy for chimeric antigen receptor T cells therapy in non-Hodgkin lymphoma: Systematic review and meta-analysis.
    Radiother Oncol. 2025;214:111258.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.